Selective Serotonin Reuptake Inhibitor Use in the Treatment of the Pediatric Non-Obsessive-Compulsive Disorder Anxiety Disorders
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The non-OCD (obsessive-compulsive disorder) anxiety disorders in the pediatric population- separation anxiety disorder, generalized anxiety disorder, and social phobia and others- are arguably the most common psychiatric disorders in this age group. Anxiety disorders, in addition to being common, also significantly impair the affected child at home, school, and with peers. A small developing evidence base suggests the selective serotonin reuptake inhibitors (SSRIs) are the pharmacological treatment of choice for pediatric non-OCD anxiety disorders. In clinical trials, SSRIs are often very effective in reducing symptoms and improving functioning and generally well tolerated. The U.S. Food and Drug Administration's (FDA) review of the safety of antidepressants in the pediatric population suggest a small, but significant, increased relative risk for suicidality adverse events on antidepressant versus placebo. Despite the apparent increased risk, the larger magnitude of benefit of the SSRIs for pediatric non-OCD anxiety disorders compared to depression suggests the benefit/risk ratio for anxiety disorders is more favorable than that for depression. This paper will review available studies on the treatment of non-OCD childhood anxiety disorders with antidepressants, including the SSRIs, and discuss pertinent safety issues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SHAFFER, D., FISHER, P., DULCAN, M. K., DAVIES, M., PIACENTINI, J., SCHWAB-STONE, M. E., LAHEY, B. B., BOURDON, K., JENSEN, P. S., BIRD, H. R., et al. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199607000-00012 · Cited by 1,587 · cited 1×
“Epidemiological studies estimate the prevalence of impairing anxiety in the pediatric population at greater than 10% (Pine 1994) with the majority of large surveys estimating the prevalence to range between 12% and 20% (Achenbach et al. 1995; Gurley et al. 1996; Shaffer et al. 1996).”
Treating anxiety disorders in children: Results of a randomized clinical trial.
Kendall, P. C. (1994) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.62.1.100 · Cited by 1,376
Therapy for youths with anxiety disorders: A second randomized clincal trial.
Kendall, P. C., Flannery-Schroeder, E., Panichelli-Mindel, S. M., Southam-Gerow, M., Henin, A., & Warman, M. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.65.3.366 · Cited by 984
Wagner, K. D., Berard, R., Stein, M. B., Wetherhold, E., Carpenter, D. J., Perera, P., Gee, M., Davy, K., & Machin, A. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1153 · Cited by 240 · cited 2×
“A very large, industry-sponsored, multicenter, randomized, 16-week, double-blind, placebo-controlled trial compared paroxetine 10–50 mg daily to placebo in 322 children and adolescents ages 8–17 years with social phobia (Wagner et al. 2004).”
Pine, D. S. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602760386888 · Cited by 73
Cited by
Assessment and Treatment of Anxiety Disorders in Children and Adolescents
Wehry, A. M., Beesdo-Baum, K., Hennelly, M. M., Connolly, S. D., & Strawn, J. R. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0591-z · Cited by 294
Comorbidity of internalizing disorders in children with oppositional defiant disorder
Boylan, K., Vaillancourt, T., Boyle, M., & Szatmari, P. (2007) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-007-0624-1 · Cited by 257
Maslowsky, J., Mogg, K., Bradley, B. P., McClure-Tone, E., Ernst, M., Pine, D. S., & Monk, C. S. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0049 · Cited by 125
Offidani, E., Fava, G. A., Tomba, E., & Baldessarini, R. J. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000345316 · Cited by 94
Patel, D. R., Feucht, C., Brown, K., & Ramsay, J. (2018) · Translational Pediatrics · doi:10.21037/tp.2017.08.05 · Cited by 62
Strawn, J. R., Compton, S. N., Robertson, B., Albano, A. M., Hamdani, M., & Rynn, M. A. (2017) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2016.0132 · Cited by 55
da Costa, C. Z. G., de Morais, R. M. C. B., Zanetta, D. M. T., Turkiewicz, G., Neto, F. L., Morikawa, M., Rodrigues, C. L., Labbadia, E. M., & Asbahr, F. R. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0110 · Cited by 31
Dudley, M., Hadzi-Pavlovic, D., Andrews, D., & Perich, T. (2008) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670802050538 · Cited by 15
Metadata
- Authors
- Seidel, L., & Walkup, J. T.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2006-03
- Volume
- 16
- Issue
- 1-2
- Pages
- 171-179
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W2002528933
- Cited by
- 36
- References
- 5
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.